Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Reproduction, Fertility, and Development
|
January 2, 2023
Decisive points for pregnancy losses in beef cattle
B D Smith, B Poliakiwski, O Polanco, et al.
The Journal of Hospital Infection
|
July 18, 2018
An outbreak of multidrug-resistant Pseudomonas aeruginosa in a burns service in the North of England: challenges of infection prevention and control in a complex setting
V Decraene, S Ghebrehewet, E Dardamissis, et al.
Cancer Research
|
April 16, 2009
DNA cross-links in human tumor cells exposed to the prodrug PR-104A: relationships to hypoxia, bioreductive metabolism, and cytotoxicity
Rachelle S Singleton, Christopher P Guise, Dianne M Ferry, et al.
Frontiers in Genetics
|
March 28, 2017
Dysbindin Deficiency Modifies the Expression of GABA Neuron and Ion Permeation Transcripts in the Developing Hippocampus
Jennifer Larimore, Stephanie A Zlatic, Miranda Arnold, et al.
Eneuro
|
July 27, 2021
Heterogeneous Expression of Nuclear Encoded Mitochondrial Genes Distinguishes Inhibitory and Excitatory Neurons
Meghan E Wynne, Alicia R Lane, Kaela S Singleton, et al.
EMBO Reports
|
February 8, 2012
The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity
Norma Masson, Rachelle S Singleton, Rok Sekirnik, et al.
Frontiers in Cellular Neuroscience
|
October 8, 2016
The Endosome Localized Arf-GAP AGAP1 Modulates Dendritic Spine Morphology Downstream of the Neurodevelopmental Disorder Factor Dysbindin
Miranda Arnold, Rebecca Cross, Kaela S Singleton, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
June 3, 2021
Mice with dysfunctional TGF-β signaling develop altered intestinal microbiome and colorectal cancer resistant to 5FU
Zhanhuai Wang, Lindsay M Hopson, Stephanie S Singleton, et al.
Cancer Research
|
February 11, 2010
The bioreductive prodrug PR-104A is activated under aerobic conditions by human aldo-keto reductase 1C3
Christopher P Guise, Maria R Abbattista, Rachelle S Singleton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2007
Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104
Adam V Patterson, Dianne M Ferry, Shelley J Edmunds, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Reproduction, Fertility, and Development
|
January 2, 2023
Decisive points for pregnancy losses in beef cattle
B D Smith, B Poliakiwski, O Polanco, et al.
The Journal of Hospital Infection
|
July 18, 2018
An outbreak of multidrug-resistant Pseudomonas aeruginosa in a burns service in the North of England: challenges of infection prevention and control in a complex setting
V Decraene, S Ghebrehewet, E Dardamissis, et al.
Cancer Research
|
April 16, 2009
DNA cross-links in human tumor cells exposed to the prodrug PR-104A: relationships to hypoxia, bioreductive metabolism, and cytotoxicity
Rachelle S Singleton, Christopher P Guise, Dianne M Ferry, et al.
Frontiers in Genetics
|
March 28, 2017
Dysbindin Deficiency Modifies the Expression of GABA Neuron and Ion Permeation Transcripts in the Developing Hippocampus
Jennifer Larimore, Stephanie A Zlatic, Miranda Arnold, et al.
Eneuro
|
July 27, 2021
Heterogeneous Expression of Nuclear Encoded Mitochondrial Genes Distinguishes Inhibitory and Excitatory Neurons
Meghan E Wynne, Alicia R Lane, Kaela S Singleton, et al.
EMBO Reports
|
February 8, 2012
The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity
Norma Masson, Rachelle S Singleton, Rok Sekirnik, et al.
Frontiers in Cellular Neuroscience
|
October 8, 2016
The Endosome Localized Arf-GAP AGAP1 Modulates Dendritic Spine Morphology Downstream of the Neurodevelopmental Disorder Factor Dysbindin
Miranda Arnold, Rebecca Cross, Kaela S Singleton, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
June 3, 2021
Mice with dysfunctional TGF-β signaling develop altered intestinal microbiome and colorectal cancer resistant to 5FU
Zhanhuai Wang, Lindsay M Hopson, Stephanie S Singleton, et al.
Cancer Research
|
February 11, 2010
The bioreductive prodrug PR-104A is activated under aerobic conditions by human aldo-keto reductase 1C3
Christopher P Guise, Maria R Abbattista, Rachelle S Singleton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2007
Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104
Adam V Patterson, Dianne M Ferry, Shelley J Edmunds, et al.
Page
of 6